Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma

Molecular Carcinogenesis

Volumn 31, Issue 4, 2001, Pages 184-191

  Kohda, Masakazu ^a   Hoshiya, Hidetoshi ^b   Katoh, Motonobu ^b   Tanaka, Isao ^a   Masuda, Ryo ^a   Takemura, Tamiko ^b   Fujiwara, Mutsunori ^a   Oshimura, Mitsuo ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Biallelic expression; Genomic imprinting; Monoallelic expression

Indexed keywords

COMPLEMENTARY DNA; RNA; SMALL NUCLEAR RIBONUCLEOPROTEIN; SOMATOMEDIN B;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; AUTOANTIGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA, UNTRANSLATED;

EID: 0034853634     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.1053     Document Type: Article

References (52)

1. Differential imprinting and expression of maternal and paternal genomes
2. Developmental consequence of imprinting of parental chromosomes by DNA methylation
3. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis
4. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest
5. Autosomal and X-chromosomal imprinting
6. Parental imprinting of the mouse insulin-like growth factor II gene
7. Parental legacy determines methylation and expression of an autosomal transgene: A molecular mechanism for parental imprinting
8. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction
9. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
10. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma
11. Loss of H19 imprinting in esophageal cancer
12. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors
13. Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor
14. Loss of imprinting of IGF2 in renal-cell carcinomas
15. Competition: A common motif for the imprinting mechanism?
16. Characteristics of imprinted genes
17. Imprinting the genome: Imprinted genes, imprinting genes, and a hypothesis for their interaction
18. Paternal expression of WT1 in human fibroblasts and lymphocytes
19. Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome
20. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas
21. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region
22. An enhancer deletion affects both H19 and Igf2 expression
23. Chromosome 11p15.5 regional imprinting: Comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors
24. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
25. Genomic imprinting and cancer
26. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer
27. Tumour-suppressor activity of H19 RNA
28. Location of enhancers is essential for the imprinting of H19 and Igf2 genes
29. Disruption of imprinting caused by deletion of the H19 gene region in mice
30. Loss of imprinting of long QT intronic transcript 1 in cotorectal cancer
31. Frequent loss of imprinting of PEG1/MEST in invasive breast cancer
32. Genomic imprinting in mammals
33. Imprinting in Prader-Willi and Angelman syndromes
34. IGF2 but not H19 shows loss of imprinting in human glioma
35. Loss of imprinting in carcinoma
36. Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome
37. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse
38. LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids
39. An Nsi I RFLP in the human long QT intronic transcript 1 (LIT1)
40. Human PEG1/MEST, an imprinted gene on chromosome 7
41. Monoallelic expression of human PEG1/MEST is paralleled by parent-specific methylation in fetuses
42. Insulin-like growth factor-1 can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro
43. Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines
44. Developmental regulation of insulin-like growth factor II mRNA in different rat tissues
45. Altered imprinting in lung cancer
46. Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability
47. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers
48. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures
49. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5
50. Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization
51. Epigenetic gene silencing in cancer
52. Aging, DNA methylation and cancer